31 – 40 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2017
-
Mark
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder : Association with tumor stage, lymph node metastases, FDG-PET findings, and survival
(
- Contribution to journal › Article
-
Mark
Re : Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Molecular classification of urothelial carcinoma : global mRNA classification versus tumour-cell phenotype classification
(
- Contribution to journal › Article
-
Mark
Long-term functional outcomes after radical cystectomy with ileal bladder substitute : does the definition of continence matter?
(
- Contribution to journal › Article
- 2015
-
Mark
Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »